Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 407 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
  Instructions 
  Search 
  IPS 
  My preferences 

 


This article has been cited by
1Conserved immunomodulatory transcriptional networks underlie antipsychotic-induced weight gain
Rizaldy C. Zapata,Besma S. Chaudry,Mariela Lopez Valencia,Dinghong Zhang,Scott A. Ochsner,Neil J. McKenna,Olivia Osborn
Translational Psychiatry.2021;11(1)
[DOI]
2Oral glucose tolerance test performance in olanzapine-treated schizophrenia-spectrum patients is predicted by BMI and triglycerides but not olanzapine dose or duration
Jeffrey Guina,Sayon Roy,Ankur Gupta,Daniel D. Langleben,Igor Elman
Human Psychopharmacology: Clinical and Experimental.2017;32(4)e2604
[DOI]
3Sex-differential effects of olanzapine vs. aripiprazole on glucose and lipid metabolism in first-episode schizophrenia
XUE-MEI ZHOU,MAO-RONG HU,MEI-YU GONG,XUE-LIANG ZOU,ZHI-MIN YU
Archives of Clinical Psychiatry (São Paulo).2019;46(2)33
[DOI]
4Female mice are protected against acute olanzapine-induced hyperglycemia
Kyle D. Medak,Logan K. Townsend,Margaret K. Hahn,David C. Wright
Psychoneuroendocrinology.2019;110(2)104413
[DOI]
5Samidorphan mitigates olanzapine-induced weight gain and metabolic dysfunction in rats and non-human primates
Jacobi I Cunningham,David J Eyerman,Mark S Todtenkopf,Reginald L Dean,Daniel R Deaver,Connie Sanchez,Mark Namchuk
Journal of Psychopharmacology.2019;33(10)1303
[DOI]